Ken Griffin West Pharmaceutical Services Inc Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 42,200 shares of WST stock, worth $8.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,200
Previous 48,200
12.45%
Holding current value
$8.9 Million
Previous $14.5 Million
4.45%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding WST
# of Institutions
814Shares Held
65.5MCall Options Held
244KPut Options Held
427K-
Vanguard Group Inc Valley Forge, PA8.99MShares$1.9 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$1.6 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.25MShares$685 Million0.04% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.11MShares$656 Million1.63% of portfolio
-
Alliancebernstein L.P. New York, NY2.59MShares$547 Million0.3% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $15.6B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...